Provided are personal care compositions comprising ester polyol esters, ester polyol esters, manufacturing methods thereof, and the use of ester polyol esters in personal care compositions.

Provided are personal care compositions comprising ester polyol esters, ester polyol esters, manufacturing methods thereof, and the use of ester polyol esters in personal care compositions.

The present application relates to monoterpenoid and phenylpropanoid carbonate esters and methods of their making and use as repellents.

Disclosed herein are hygiene product pods and a method of using the hygiene product pods. A hygiene product pod can include a water-soluble envelope and a hygiene product sealed in the water-soluble envelope. A hygiene product as described herein can comprise a non-aqueous carrier. A non-aqueous carrier as described herein can comprise a polyol solvent and a polyglyceryl fatty acid ester (PGEs) chassis.

Compositions and topical formulations comprising a PPAR agonist complex comprising glyceryl linoleate, glyceryl linolenate, xymenynic acid, and Pterocarpus marsupium bark extract are described herein. Methods of inducing skin barrier repair, increasing the biosynthesis of barrier lipids and proteins in the skin, stimulating hair growth, treating acne and combinations thereof utilizing the composition and topical formulations are also provided herein.

Water-in-oil type emulsion cosmetics containing (a) polyaspartic acid or a salt thereof, (b) a spherical powder, (c) an oily component, (d) a lipophilic surfactant, (e) a pigment, and (f) water can achieve superior makeup effects, good moist feeling, superior emulsion stability and pigment dispersibility.

Water-in-oil type emulsion cosmetics containing (a) polyaspartic acid or a salt thereof, (b) a spherical powder, (c) an oily component, (d) a lipophilic surfactant, (e) a pigment, and (f) water can achieve superior makeup effects, good moist feeling, superior emulsion stability and pigment dispersibility.

A three-part method of cleaning a user's teeth and/or gums is disclosed. First, a user applies a tonic of essential oils to the user's teeth and/or gums by either brushing, rubbing, rinsing and/or flossing with the tonic thereby destroying harmful bacteria. Second, the user brushes with a toothpaste having nano-hydroxyapatite being particles of 50 nanometers or smaller. The nano-hydroxyapatite is absorbed into the surface opening inside dentinal tubules of the teeth. Third, the user seeds their mouth with an oral probiotic having beneficial bacteria. The third step must come after both the first and second steps.

A three-part method of cleaning a user's teeth and/or gums is disclosed. First, a user applies a tonic of essential oils to the user's teeth and/or gums by either brushing, rubbing, rinsing and/or flossing with the tonic thereby destroying harmful bacteria. Second, the user brushes with a toothpaste having nano-hydroxyapatite being particles of 50 nanometers or smaller. The nano-hydroxyapatite is absorbed into the surface opening inside dentinal tubules of the teeth. Third, the user seeds their mouth with an oral probiotic having beneficial bacteria. The third step must come after both the first and second steps.

The present invention relates to pre-formulations comprising low viscosity, non-liquid crystalline, mixtures of: a) at least one neutral diacyl lipid and/or at least one tocopherol; b) at least one phospholipid; c) at least one biocompatible, oxygen containing, low viscosity organic solvent;
wherein at least one bioactive agent is dissolved or dispersed in the low viscosity mixture and wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with an aqueous fluid. The preformulations are suitable for generating parenteral, non-parenteral and topical depot compositions for sustained release of active agents. The invention additionally relates to a method of delivery of an active agent comprising administration of a preformulation of the invention, a method of treatment comprising administration of a preformulation of the invention and the use of a preformulation of the invention in a method for the manufacture of a medicament.